| Literature DB >> 30338667 |
Takuro Washio1,2, Jennifer R Vranish3, Jasdeep Kaur3, Benjamin E Young3, Keisho Katayama4, Paul J Fadel3, Shigehiko Ogoh1.
Abstract
The mechanism(s) for the increased occurrence of a grayout or blackout, syncope, immediately after heavy resistance exercise are unclear. It is well-known that orthostatic stress increases the occurrence of postexercise syncope. In addition, previous findings have suggested that hypo-perfusion, especially in the posterior cerebral circulation rather than anterior cerebral circulation, may be associated with the occurrence of syncope. Herein, we hypothesized that the postexercise decrease in posterior, but not anterior, cerebral blood flow (CBF) would be greater during orthostatic stress. Nine healthy subjects performed 3-min isometric handgrip (HG) at 30% maximum voluntary contraction without (CONTROL) and during lower body negative pressure (LBNP; -40 Torr) while vertebral artery (VA) blood flow, as an index of posterior CBF, and middle cerebral artery blood velocity (MCAv), as an index of anterior CBF, were measured. Immediately after HG (0 to 15 sec of recovery phase), mean arterial pressure decreased but there was no difference in this reduction between CONTROL and LBNP conditions (-15.4 ± 4.0% and -17.0 ± 6.2%, P = 0.42). Similarly, MCAv decreased following exercise and was unaffected by the application of LBNP (P = 0.22). In contrast, decreases in VA blood flow immediately following HG during LBNP were significantly greater compared to CONTROL condition (-24.2 ± 9.5% and -13.4 ± 6.6%, P = 0.005). These findings suggest that the decrease in posterior CBF immediately following exercise was augmented by LBNP, whereas anterior CBF appeared unaffected. Thus, the posterior cerebral circulation may be more sensitive to orthostatic stress during the postexercise period.Entities:
Keywords: Anterior cerebral blood flow; middle cerebral artery blood velocity; orthostatic stress; resistance exercise; syncope; vertebral artery blood flow
Mesh:
Year: 2018 PMID: 30338667 PMCID: PMC6194212 DOI: 10.14814/phy2.13886
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Cardiovascular measurements at resting baseline, during handgrip exercise and recovery
| Baseline | HG | Re1 | Re2 | Re3 | Re4 |
| |||
|---|---|---|---|---|---|---|---|---|---|
| LBNP | Time | Interaction | |||||||
| HR (beats/min) | |||||||||
| CONTROL | 60.6 ± 12.2 | 83.7 ± 13.0 | 72.3 ± 13.8 | 66.3 ± 12.4 | 61.0 ± 11.9 | 60.5 ± 11.4 | 0.004 | <0.001 | 0.823 |
| LBNP | 71.5 ± 14.2 | 95.4 ± 19.2 | 85.2 ± 21.4 | 76.2 ± 19.9 | 73.8 ± 16.2 | 74.0 ± 16.4 | |||
| SBP (mmHg) | |||||||||
| CONTROL | 133.8 ± 14.1 | 166.0 ± 16.6 | 148.1 ± 17.0 | 139.3 ± 16.4 | 140.4 ± 14.8 | 138.8 ± 13.8 | 0.023 | <0.001 | 0.160 |
| LBNP | 130.2 ± 21.9 | 163.2 ± 23.5 | 142.6 ± 21.2 | 127.9 ± 17.4 | 126.9 ± 15.4 | 125.9 ± 9.7 | |||
| DBP (mmHg) | |||||||||
| CONTROL | 71.1 ± 8.1 | 91.9 ± 8.0 | 74.9 ± 8.7 | 72.8 ± 7.5 | 74.8 ± 7.1 | 75.4 ± 6.2 | 0.828 | <0.001 | 0.552 |
| LBNP | 71.6 ± 10.6 | 93.8 ± 11.5 | 74.5 ± 10.6 | 71.6 ± 8.7 | 74.5 ± 7.0 | 73.6 ± 4.8 | |||
| MAP (mmHg) | |||||||||
| CONTROL | 91.8 ± 10.7 | 120.2 ± 10.5 | 101.8 ± 11.6 | 95.9 ± 10.0 | 97.7 ± 9.0 | 97.4 ± 8.1 | 0.003 | <0.001 | 0.747 |
| LBNP | 88.3 ± 12.8 | 115.6 ± 10.7 | 95.8 ± 10.8 | 89.3 ± 9.4 | 91.6 ± 7.6 | 90.6 ± 4.0 | |||
| SV (mL) | |||||||||
| CONTROL | 116.6 ± 13.3 | 122.6 ± 12.3 | 126.5 ± 11.3 | 125.8 ± 11.4 | 125.4 ± 9.2 | 121.8 ± 8.5 | <0.001 | 0.157 | 0.211 |
| LBNP | 90.8 ± 14.0 | 92.3 ± 18.6 | 97.7 ± 13.3 | 94.4 ± 10.7 | 88.3 ± 13.2 | 88.5 ± 12.9 | |||
| CO (L/min) | |||||||||
| CONTROL | 7.1 ± 1.9 | 9.6 ± 1.9 | 9.2 ± 2.3 | 8.4 ± 2.0 | 7.7 ± 1.6 | 7.4 ± 1.5 | 0.003 | 0.002 | 0.639 |
| LBNP | 6.5 ± 1.6 | 8.4 ± 1.5 | 8.2 ± 1.8 | 7.1 ± 1.5 | 6.4 ± 1.2 | 6.5 ± 1.4 | |||
| EtCO2 (mmHg) | |||||||||
| CONTROL | 42.6 ± 2.8 | 41.4 ± 3.3 | 41.0 ± 2.2 | 42.5 ± 2.0 | 42.1 ± 2.2 | 40.4 ± 3.2 | <0.001 | 0.012 | 0.505 |
| LBNP | 40.2 ± 3.1 | 39.3 ± 3.4 | 38.0 ± 2.2 | 39.5 ± 1.7 | 39.8 ± 2.4 | 39.3 ± 2.4 | |||
Data are mean ± SD (n = 9); HG, handgrip exercise; Re1, postexercise 0–15 sec; Re2, postexercise 15–30 sec; Re3, postexercise 30–45 sec; Re4, postexercise 45–60 sec HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; SV, stroke volume; CO, cardiac output; EtCO2, End‐tidal carbon dioxide.
Cerebral vascular measurements at resting baseline, during handgrip exercise and recovery
| Baseline | HG | Re1 | Re2 | Re3 | Re4 |
| |||
|---|---|---|---|---|---|---|---|---|---|
| LBNP | Time | Interaction | |||||||
| VA blood flow (mL/min) | |||||||||
| CONTROL | 118.4 ± 24.0 | 153.7 ± 25.7 | 133.7 ± 27.2 | 122.3 ± 24.1 | 122.1 ± 21.2 | 115.2 ± 23.2 | 0.355 | <0.001 | 0.014 |
| LBNP | 115.1 ± 24.9 | 153.3 ± 26.2 | 117.5 ± 30.5 | 119.2 ± 24.8 | 116.0 ± 24.2 | 116.8 ± 23.2 | |||
| VA CVC (mL/min/mmHg) | |||||||||
| CONTROL | 1.31 ± 0.34 | 1.28 ± 0.23 | 1.32 ± 0.28 | 1.30 ± 0.35 | 1.26 ± 0.27 | 1.19 ± 0.28 | 0.622 | 0.354 | 0.040 |
| LBNP | 1.33 ± 0.37 | 1.33 ± 0.23 | 1.22 ± 0.25 | 1.35 ± 0.33 | 1.27 ± 0.28 | 1.29 ± 0.29 | |||
| MCAv (cm/s) | |||||||||
| CONTROL | 58.1 ± 10.8 | 67.0 ± 12.2 | 64.1 ± 9.7 | 60.7 ± 10.0 | 59.6 ± 9.6 | 59.3 ± 11.9 | 0.421 | <0.001 | 0.247 |
| LBNP | 59.1 ± 11.8 | 68.1 ± 11.8 | 62.6 ± 9.1 | 58.1 ± 8.8 | 59.0 ± 9.9 | 56.4 ± 9.9 | |||
| MCA CVCi (cm/s/mmHg) | |||||||||
| CONTROL | 1.64 ± 0.41 | 1.84 ± 0.37 | 1.61 ± 0.33 | 1.62 ± 0.32 | 1.68 ± 0.31 | 1.72 ± 0.36 | 0.016 | 0.001 | 0.837 |
| LBNP | 1.54 ± 0.38 | 1.73 ± 0.38 | 1.53 ± 0.25 | 1.55 ± 0.22 | 1.57 ± 0.23 | 1.64 ± 0.27 | |||
Data are mean ± SD (n = 9); HG, handgrip exercise; Re1, postexercise 0–15 sec; Re2, postexercise 15–30 sec; Re3, postexercise 30–45 sec; Re4, postexercise 45–60 sec VA CVC, vertbral artery cerebral vascular conductance; MCA CVCi, middle cerebral artery cerebral vascular conductance index. *P < 0.05, versus CONTROL. †P < 0.05, versus baseline. §P < 0.05, versus HG. One subject was excluded from the analysis due to excessive noise in the MCAv signal.
Figure 1Relative changes in mean arterial pressure (MAP), vertebral artery (VA) blood flow, and middle cerebral artery velocity (MCAv, n = 8) from each resting baseline. Data are mean ± SD (n = 9); HG, handgrip exercise; Re1, post exercise 0–15 sec; Re2, postexercise 15–30 sec; Re3, postexercise 30–45 sec; Re4, postexercise 45–60 sec. *P < 0.05, versus CONTROL. † P < 0.05, versus baseline. § P < 0.05, versus HG.
Figure 2Relative changes in mean arterial pressure (MAP), vertebral artery (VA) blood flow, middle cerebral artery velocity (MCAv, n = 8), VA cerebral vascular conductance (VA CVC), and MCA cerebral vascular conductance index (MCA CVCi) from handgrip (HG) to postexercise recovery (Re1, 0–15 sec) with or without lower body negative pressure. Data are mean ± SD (n = 9). *P < 0.05, versus CONTROL.
Figure 3Relationship between relative changes in vertebral artery (VA, n = 9) blood flow or middle cerebral artery velocity (MCAv, n = 8) and mean arterial pressure (MAP) from handgrip to postexercise recovery (Re1, 0–15 sec) with or without lower body negative pressure.